Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Havas

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Magnetic Resonance Imaging Clinics of North America|December 8, 2009
MRI in dementiaReinhold Schmidt, Daniel Havas, Stefan Ropele, et al.
Neurologic Clinics|December 6, 2008
MRI in dementiaReinhold Schmidt, Daniel Havas, Stefan Ropele, et al.
Journal of Cellular and Molecular Medicine|April 29, 2018
Development of GMP-1 a molecular chaperone network modulator protecting mitochondrial function and its assessment in fly and mice models of Alzheimer's diseasePavel F Pavlov, Birgit Hutter-Paier, Daniel Havas, et al.
International Journal of Molecular Sciences|May 7, 2025
Target Validation Studies of PS48, a PDK-1 Allosteric Agonist, for the Treatment of Alzheimer's Disease Phenotype in APP/PS1 Transgenic MiceHenry W Querfurth, Cynthia Lemere, Jason Ciola, et al.
Journal of Alzheimer'S Disease : JAD|March 16, 2011
A longitudinal study of behavioral deficits in an AβPP transgenic mouse model of Alzheimer's diseaseDaniel Havas, Birgit Hutter-Paier, Kiren Ubhi, et al.
Neurobiology of Aging|May 7, 2013
Impact of ApoB-100 expression on cognition and brain pathology in wild-type and hAPPsl miceTina Löffler, Stefanie Flunkert, Daniel Havas, et al.
Journal of Neuroinflammation|June 3, 2014
Neuroinflammation and related neuropathologies in APPSL mice: further value of this in vivo model of Alzheimer's diseaseTina Löffler, Stefanie Flunkert, Daniel Havas, et al.
Neuro-Degenerative Diseases|June 27, 2015
Influence of Lentiviral β-Synuclein Overexpression in the Hippocampus of a Transgenic Mouse Model of Alzheimer's Disease on Amyloid Precursor Protein Metabolism and PathologyStefanie Krassnig, Cornelia Schweinzer, Nicole Taub, et al.
BMC Neuroscience|January 11, 2013
Time course and progression of wild type α-synuclein accumulation in a transgenic mouse modelDavid Amschl, Jörg Neddens, Daniel Havas, et al.
Journal of Alzheimer'S Disease : JAD|January 17, 2013
In vivo and ex vivo imaging of amyloid-β cascade aggregates with a Pronucleon™ peptideAndrew C Nyborg, Jonathan R Moll, Renee D Wegrzyn, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Magnetic Resonance Imaging Clinics of North America|December 8, 2009
MRI in dementiaReinhold Schmidt, Daniel Havas, Stefan Ropele, et al.
Neurologic Clinics|December 6, 2008
MRI in dementiaReinhold Schmidt, Daniel Havas, Stefan Ropele, et al.
Journal of Cellular and Molecular Medicine|April 29, 2018
Development of GMP-1 a molecular chaperone network modulator protecting mitochondrial function and its assessment in fly and mice models of Alzheimer's diseasePavel F Pavlov, Birgit Hutter-Paier, Daniel Havas, et al.
International Journal of Molecular Sciences|May 7, 2025
Target Validation Studies of PS48, a PDK-1 Allosteric Agonist, for the Treatment of Alzheimer's Disease Phenotype in APP/PS1 Transgenic MiceHenry W Querfurth, Cynthia Lemere, Jason Ciola, et al.
Journal of Alzheimer'S Disease : JAD|March 16, 2011
A longitudinal study of behavioral deficits in an AβPP transgenic mouse model of Alzheimer's diseaseDaniel Havas, Birgit Hutter-Paier, Kiren Ubhi, et al.
Neurobiology of Aging|May 7, 2013
Impact of ApoB-100 expression on cognition and brain pathology in wild-type and hAPPsl miceTina Löffler, Stefanie Flunkert, Daniel Havas, et al.
Journal of Neuroinflammation|June 3, 2014
Neuroinflammation and related neuropathologies in APPSL mice: further value of this in vivo model of Alzheimer's diseaseTina Löffler, Stefanie Flunkert, Daniel Havas, et al.
Neuro-Degenerative Diseases|June 27, 2015
Influence of Lentiviral β-Synuclein Overexpression in the Hippocampus of a Transgenic Mouse Model of Alzheimer's Disease on Amyloid Precursor Protein Metabolism and PathologyStefanie Krassnig, Cornelia Schweinzer, Nicole Taub, et al.
BMC Neuroscience|January 11, 2013
Time course and progression of wild type α-synuclein accumulation in a transgenic mouse modelDavid Amschl, Jörg Neddens, Daniel Havas, et al.
Journal of Alzheimer'S Disease : JAD|January 17, 2013
In vivo and ex vivo imaging of amyloid-β cascade aggregates with a Pronucleon™ peptideAndrew C Nyborg, Jonathan R Moll, Renee D Wegrzyn, et al.
Pageof 3